• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能遗传多样性、药物敏感性改变和精准医学。

functional genetic diversity, altered drug sensitivity, and precision medicine.

机构信息

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States.

出版信息

Front Cell Infect Microbiol. 2022 Oct 3;12:1007958. doi: 10.3389/fcimb.2022.1007958. eCollection 2022.

DOI:10.3389/fcimb.2022.1007958
PMID:36262182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9574059/
Abstract

In the face of the unrelenting global burden of tuberculosis (TB), antibiotics remain our most effective tools to save lives and control the spread of (Mtb). However, we confront a dual challenge in our use of antibiotics: simplifying and shortening the TB drug regimen while also limiting the emergence and propagation of antibiotic resistance. This task is now more feasible due to the increasing availability of bacterial genomic data at or near the point of care. These resources create an opportunity to envision how integration of bacterial genetic determinants of antibiotic response into treatment algorithms might transform TB care. Historically, Mtb drug resistance studies focused on mutations in genes encoding antibiotic targets and the resulting increases in the minimal inhibitory concentrations (MICs) above a breakpoint value. But recent progress in elucidating the effects of functional genetic diversity in Mtb has revealed various genetic loci that are associated with drug phenotypes such as low-level MIC increases and tolerance which predict the development of resistance and treatment failure. As a result, we are now poised to advance precision medicine approaches in TB treatment. By incorporating information regarding Mtb genetic characteristics into the development of drug regimens, clinical care which tailors antibiotic treatment to maximize the likelihood of success has come into reach.

摘要

面对结核病(TB)全球负担的持续增加,抗生素仍然是挽救生命和控制(Mtb)传播的最有效工具。然而,在使用抗生素时,我们面临着双重挑战:既要简化和缩短结核病药物治疗方案,又要限制抗生素耐药性的出现和传播。由于接近护理点的细菌基因组数据的可用性不断增加,这一任务现在变得更加可行。这些资源为我们提供了一个机会,可以设想将抗生素反应的细菌遗传决定因素整合到治疗算法中,如何改变结核病的护理方式。从历史上看,Mtb 药物耐药性研究主要集中在编码抗生素靶标的基因中的突变以及由此导致的最小抑菌浓度(MIC)超过断点值的增加。但最近在阐明 Mtb 功能遗传多样性的影响方面取得的进展揭示了与药物表型相关的各种遗传基因座,例如 MIC 水平升高和耐受性的降低,这些表型预测耐药性的发展和治疗失败。因此,我们现在准备在结核病治疗中推进精准医学方法。通过将有关 Mtb 遗传特征的信息纳入药物治疗方案的制定中,我们可以实现临床护理,根据 Mtb 遗传特征调整抗生素治疗,最大限度地提高成功的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d9/9574059/57a7af5da3c1/fcimb-12-1007958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d9/9574059/57a7af5da3c1/fcimb-12-1007958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d9/9574059/57a7af5da3c1/fcimb-12-1007958-g001.jpg

相似文献

1
functional genetic diversity, altered drug sensitivity, and precision medicine.功能遗传多样性、药物敏感性改变和精准医学。
Front Cell Infect Microbiol. 2022 Oct 3;12:1007958. doi: 10.3389/fcimb.2022.1007958. eCollection 2022.
2
Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in .中心碳代谢重编程作为产生药物耐受性和耐药性的机制。
Front Cell Infect Microbiol. 2022 Aug 22;12:958240. doi: 10.3389/fcimb.2022.958240. eCollection 2022.
3
The evolving biology of drug resistance.耐药性的不断演变的生物学。
Front Cell Infect Microbiol. 2022 Oct 5;12:1027394. doi: 10.3389/fcimb.2022.1027394. eCollection 2022.
4
High-throughput phenogenotyping clinical strains reveals bacterial determinants of treatment outcomes.高通量表型基因分型临床菌株揭示治疗结果的细菌决定因素。
bioRxiv. 2023 Apr 10:2023.04.09.536166. doi: 10.1101/2023.04.09.536166.
5
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
6
Genetic diversity and drug resistance of Mycobacterium tuberculosis in Yunnan, China.中国云南结核分枝杆菌的遗传多样性和耐药性。
J Clin Lab Anal. 2019 Jun;33(5):e22884. doi: 10.1002/jcla.22884. Epub 2019 Mar 21.
7
Tuberculosis结核病
8
Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment.宿主内结核分枝杆菌多样性和治疗期间异质性耐药的动力学。
EBioMedicine. 2020 May;55:102747. doi: 10.1016/j.ebiom.2020.102747. Epub 2020 Apr 28.
9
Rapid Identification of Drug Resistance and Phylogeny in M. tuberculosis, Directly from Sputum Samples.从痰样本中直接快速鉴定结核分枝杆菌的耐药性和系统发育。
Microbiol Spectr. 2022 Oct 26;10(5):e0125222. doi: 10.1128/spectrum.01252-22. Epub 2022 Sep 14.
10
Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Rifampicin-Resistant Mycobacterium tuberculosis in Hunan, China, Revealed by Whole-Genome Sequencing.中国湖南利福平耐药结核分枝杆菌的耐药特征、遗传多样性和传播动态的全基因组测序研究
Microbiol Spectr. 2022 Feb 23;10(1):e0154321. doi: 10.1128/spectrum.01543-21. Epub 2022 Feb 16.

引用本文的文献

1
Endoplasmic Reticulum Stress in Tuberculosis: Molecular Bases and Pathophysiological Implications in the Immunopathogenesis of the Disease.结核病中的内质网应激:疾病免疫发病机制的分子基础及病理生理学意义
Int J Mol Sci. 2025 May 9;26(10):4522. doi: 10.3390/ijms26104522.
2
In vitro activity of rifampicin, rifapentine and rifabutin in combination with their 25-deacetyl-metabolites against various Mycobacterium tuberculosis lineages.利福平、利福喷汀和利福布汀及其25-去乙酰代谢物联合对不同结核分枝杆菌谱系的体外活性。
Ann Clin Microbiol Antimicrob. 2025 Feb 28;24(1):16. doi: 10.1186/s12941-025-00784-w.
3
Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of .

本文引用的文献

1
Tuberculosis treatment failure associated with evolution of antibiotic resilience.结核病治疗失败与抗生素耐药性的进化有关。
Science. 2022 Dec 9;378(6624):1111-1118. doi: 10.1126/science.abq2787. Epub 2022 Dec 8.
2
Loss of RNase J leads to multi-drug tolerance and accumulation of highly structured mRNA fragments in Mycobacterium tuberculosis.RNase J 的缺失导致结核分枝杆菌的多药耐药性和高度结构化的 mRNA 片段的积累。
PLoS Pathog. 2022 Jul 13;18(7):e1010705. doi: 10.1371/journal.ppat.1010705. eCollection 2022 Jul.
3
CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis.
由……的抗σ因子RshA功能丧失突变赋予的多药耐受性 。 你提供的原文似乎不完整,句末“of.”后面应该还有具体内容。
Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0105124. doi: 10.1128/aac.01051-24. Epub 2024 Oct 29.
4
Leading Paediatric Infectious Diseases-Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions.前沿儿科传染病——口服药物治疗干预的当前趋势、差距及未来前景
Pharmaceutics. 2024 May 26;16(6):712. doi: 10.3390/pharmaceutics16060712.
5
Identification of bacterial determinants of tuberculosis infection and treatment outcomes: a phenogenomic analysis of clinical strains.结核感染和治疗结局的细菌决定因素鉴定:临床分离株的表型基因组分析。
Lancet Microbe. 2024 Jun;5(6):e570-e580. doi: 10.1016/S2666-5247(24)00022-3. Epub 2024 May 8.
6
Public health implementation of pathogen genomics: the role for accreditation and application of ISO standards.病原体基因组学在公共卫生中的实施:认证和应用 ISO 标准的作用。
Microb Genom. 2023 Aug;9(8). doi: 10.1099/mgen.0.001097.
CRISPRi 化学遗传学和比较基因组学鉴定介导结核分枝杆菌药物效力的基因。
Nat Microbiol. 2022 Jun;7(6):766-779. doi: 10.1038/s41564-022-01130-y. Epub 2022 May 30.
4
Whole-genome sequencing of Mycobacterium tuberculosis from Cambodia.柬埔寨分枝杆菌全基因组测序。
Sci Rep. 2022 May 11;12(1):7693. doi: 10.1038/s41598-022-10964-9.
5
CinA mediates multidrug tolerance in Mycobacterium tuberculosis.西那卡塞通过调节钙敏感受体抑制甲状旁腺素的分泌。
Nat Commun. 2022 Apr 22;13(1):2203. doi: 10.1038/s41467-022-29832-1.
6
Mycobacterium tuberculosis Lineages Associated with Mutations and Drug Resistance in Isolates from India.印度分离株中与突变和耐药性相关的结核分枝杆菌谱系。
Microbiol Spectr. 2022 Jun 29;10(3):e0159421. doi: 10.1128/spectrum.01594-21. Epub 2022 Apr 20.
7
The 2021 WHO catalogue of complex mutations associated with drug resistance: A genotypic analysis.《2021年世界卫生组织与耐药性相关的复杂突变目录:基因型分析》
Lancet Microbe. 2022 Apr;3(4):e265-e273. doi: 10.1016/S2666-5247(21)00301-3.
8
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.非洲和印度儿童中非重症结核病的更短治疗疗程。
N Engl J Med. 2022 Mar 10;386(10):911-922. doi: 10.1056/NEJMoa2104535.
9
Genomic signatures of pre-resistance in Mycobacterium tuberculosis.结核分枝杆菌耐药前的基因组特征。
Nat Commun. 2021 Dec 15;12(1):7312. doi: 10.1038/s41467-021-27616-7.
10
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.采用Xpert MTB/XDR检测法检测异烟肼、氟喹诺酮、乙硫异烟胺、阿米卡星、卡那霉素和卷曲霉素耐药性:一项横断面多中心诊断准确性研究。
Lancet Infect Dis. 2022 Feb;22(2):242-249. doi: 10.1016/S1473-3099(21)00452-7. Epub 2021 Oct 7.